Global Migraine Epidemiology and Patient Flow Analysis - 2017
Fore Pharma announced the results of its Migraine patients study in a new report 'Global Migraine Epidemiology and Patient Flow Analysis - 2017'.
LONDON, Nov. 16, 2017 /PRNewswire/ --
Download the full report: https://www.reportbuyer.com/product/3895258
The report provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Migraine derived from epidemiological analysis, percentage of patients diagnosed with Migraine, and percentage of patients treated with a therapy.
The study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Migraine Patient Flow
- Migraine Prevalence
- Migraine Diagnosed Patients
- Migraine Treated Patients
Download the full report: https://www.reportbuyer.com/product/3895258
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article